Management of asthma in adults: current therapy and future directions

被引：25

作者：

Green, RH ^{[1
]}

Brightling, CE ^{[1
]}

Pavord, ID ^{[1
]}

Wardlaw, AJ ^{[1
]}

机构：

[1] Glenfield Hosp, Dept Resp Med & Thorac Surg, Inst Lung Hlth, Leicester LE3 9QP, Leics, England

来源：

POSTGRADUATE MEDICAL JOURNAL | 2003年 / 79卷 / 931期

关键词：

D O I：

10.1136/pmj.79.931.259

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Asthma is increasing in prevalence worldwide and results in significant use of healthcare resources. Although most patients with asthma can be adequately treated with inhaled corticosteroids, an important number of patients require additional therapy and an increasing number of options are available. A further minority of patients develop severe persistent asthma which remains difficult to manage despite current pharmacological therapies. This review discusses the various treatment options currently available for each stage of asthma severity, highlights some of the limitations of current management, and outlines directions which may improve the management of asthma in the future.

引用

页码：259 / 267

页数：9

共 110 条

[61] Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice [J].

Lim, S ;

Jatakanon, A ;

Gordon, D ;

Macdonald, C ;

Chung, KF ;

Barnes, PJ .

THORAX, 2000, 55 (10) :837-841

[62] Impact of genetic polymorphisms of the β2-adrenergic receptor on albuterol bronchodilator pharmacodynamics [J].

Lima, JJ ;

Thomason, DB ;

Mohamed, MHN ;

Eberle, LV ;

Self, TH ;

Johnson, JA .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (05) :519-525

[63] Effects of adding a leukotriene antagonist or a long-acting beta2-agonist in asthmatic patients with the glycine-16 beta2-adrenoceptor genotype [J].

Lipworth, BJ ;

Dempsey, OJ ;

Aziz, I ;

Wilson, AM .

AMERICAN JOURNAL OF MEDICINE, 2000, 109 (02) :114-121

[64] Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma [J].

Lock, SH ;

Kay, AB ;

Barnes, NC .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 153 (02) :509-514

[65] Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients [J].

Löfdahl, CG ;

Reiss, TF ;

Leff, JA ;

Israel, E ;

Noonan, MJ ;

Finn, AF ;

Seidenberg, BC ;

Capizzi, T ;

Kundu, S ;

Godard, P .

BMJ-BRITISH MEDICAL JOURNAL, 1999, 319 (7202) :87-90

[66] Impact of fluticasone propionate powder on health-related quality of life in patients with moderate asthma [J].

Mahajan, P ;

Okamoto, LJ ;

Schaberg, A ;

Kellerman, D ;

Schoenwetter, WF .

JOURNAL OF ASTHMA, 1997, 34 (03) :227-234

[67]

MAK VHF, 1992, EUR RESPIR J, V5, P1068

[68] INHIBITION OF EXERCISE-INDUCED BRONCHOCONSTRICTION BY MK-571, A POTENT LEUKOTRIENE-D4 RECEPTOR ANTAGONIST [J].

MANNING, PJ ;

WATSON, RM ;

MARGOLSKEE, DJ ;

WILLIAMS, VC ;

SCHWARTZ, JI ;

OBYRNE, PM .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (25) :1736-1739

[69] Polymorphisms of the 5′ leader cistron of the human β2-adrenergic receptor regulate receptor expression [J].

McGraw, DW ;

Forbes, SL ;

Kramer, LA ;

Liggett, SB .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (11) :1927-1932

[70]

*NAT HEART LUNG BL, 1995, NAT HEART LUNG BLOOD

← 2 3 4 5 6 7 8 9 10 11 →